In the past four years, URL Pharma has invested over $200 million in R&D. URL Pharma’s research focuses on developing scientific and medical innovations for existing compounds which also have established patent and regulatory exclusivity or high commercial barriers. In 2004, the company had fewer than 10 patents or patent applications. As of early 2008, to protect our investments in innovations, products and technologies, we acheived multiple issued US patents, over 40 patent applications pending at the U.S. Patent and Trademark Office, and many more patent applications being drafted.